Trial intelligence / Profile preview

Randomized study of FCU-08 in acute kidney injury requiring continuous blood purification

jRCT2080223207Phase 3Completed

Sponsor
Fuso Pharmaceutical Industries
Start
May 2016
Countries
1
01

Overview

Phase 3, randomised trial of FCU-08 in acute kidney failure (AKF) (2 arms), sponsored by Fuso Pharmaceutical Industries. Started May 2016; status: completed.

02

Drugs

FCU-08
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on jRCT2080223207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call